Tackling Treatment Uncertainties – Together
2006 Conference
The James Lind Alliance (JLA) has been established to foster discussion and debate among patients (and carers) and clinicians (doctors, nurses, therapists and others who treat patients) about the uncertainties of effects of treatments. The JLA supports the development of working partnerships of patient and clinician groups to address their areas of uncertainties together. This is achieved with a two-step process:
- Identifying the areas of uncertainty
- Prioritising the areas of uncertainty
Their session will seek to:
- Stimulate debate around the perceived priorities for research – drawing on the views and experiences of the audience
- Alert attendees to the JLA initiative and provide an outline of progress so far
- Share challenges and problems
- Demonstrate how uncertainties are collected on the web-based database (DUETs)
- Seek comments which can help guide the continuing development of the JLA
- Encourage participants to consider affiliating to the JLA
Tackling treatment uncertainties together (Patients and Clinicians)
Authors
Fenton ~ Mark
Editor, DUETslnbr Mark Fenton trained as a mental health nurse, then in psychodynamic psychotherapy, sociology and epidemiology. Author of many systematic reviews for the Cochrane Schizophrenia group, he now works part time for the James Lind Initiative as Editor of DUETs, whilst continuing with the Cochrane Schizophrenia Group.
View all articles by this authorFirkins ~ Lester
Chair, Strategy and Development Group, James Lind Alliance
View all articles by this authorScadding ~ John
James Lind Alliance Strategy and Development Group. John Scadding is consultant neurologist and former Medical Director at the National Hospital for Neurology and Neurosurgery, London. Until 2003 he was also neurologist at Whittington Hospital. In 2002 he was appointed Associate Dean at the Royal Society of Medicine
View all articles by this author« Go back
